Target type: biologicalprocess
A receptor-mediated endocytosis process that results in the internalization of a neurotransmitter receptor. [GOC:dos]
Neurotransmitter receptor internalization is a crucial process in neuronal signaling that regulates the strength and duration of synaptic transmission. It involves the removal of neurotransmitter receptors from the cell surface, primarily through endocytosis. This process can be triggered by various factors, including ligand binding, phosphorylation, and interactions with other proteins. The internalization pathway typically involves the following steps:
1. **Ligand Binding:** Neurotransmitter binding to its receptor initiates the internalization process. This binding can induce conformational changes in the receptor, exposing internalization motifs that interact with adaptor proteins.
2. **Adaptor Protein Recruitment:** Adaptor proteins, such as clathrin and AP2, recognize these motifs and assemble around the receptor, forming a coat that deforms the plasma membrane.
3. **Clathrin-mediated Endocytosis:** The clathrin coat acts as a scaffolding structure, invaginating the membrane and forming a clathrin-coated vesicle. The receptor, along with associated proteins, is enclosed within the vesicle.
4. **Vesicle Budding:** The vesicle pinches off from the membrane, releasing it into the cytoplasm.
5. **Uncoating and Trafficking:** Once internalized, the vesicle undergoes uncoating, shedding the clathrin coat. The vesicle then travels through the endocytic pathway, potentially undergoing sorting and recycling.
6. **Recycling or Degradation:** The internalized receptor can follow two main fates:
* **Recycling:** The receptor can be returned to the plasma membrane, restoring its signaling capacity.
* **Degradation:** The receptor can be transported to lysosomes for degradation, effectively downregulating signaling.
The specific internalization pathway and fate of the receptor can vary depending on the receptor type, the cell type, and the signaling context. This process is tightly regulated and plays a vital role in synaptic plasticity, learning, and memory formation. Disruptions in receptor internalization can lead to neurological disorders.'
"
Protein | Definition | Taxonomy |
---|---|---|
Voltage-dependent calcium channel gamma-3 subunit | A voltage-dependent calcium channel gamma-3 subunit that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60359] | Homo sapiens (human) |
Voltage-dependent calcium channel gamma-4 subunit | A voltage-dependent calcium channel gamma-4 subunit that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UBN1] | Homo sapiens (human) |
Voltage-dependent calcium channel gamma-2 subunit | A voltage-dependent calcium channel gamma-2 subunit that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y698] | Homo sapiens (human) |
Voltage-dependent calcium channel gamma-8 subunit | A voltage-dependent calcium channel gamma-8 subunit that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8WXS5] | Homo sapiens (human) |
Voltage-dependent calcium channel gamma-5 subunit | A voltage-dependent calcium channel gamma-5 subunit that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UF02] | Homo sapiens (human) |
Voltage-dependent calcium channel gamma-7 subunit | A voltage-dependent calcium channel gamma-7 subunit that is encoded in the genome of human. [PRO:DNx, UniProtKB:P62955] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
tacrine | tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease. Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. | acridines; aromatic amine | EC 3.1.1.7 (acetylcholinesterase) inhibitor |
nimodipine | nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm. Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure. | 2-methoxyethyl ester; C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; isopropyl ester | antihypertensive agent; calcium channel blocker; cardiovascular drug; vasodilator agent |
ith 4012 |